Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1

Status

Withdrawn 2Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 5OTHER_GOV 1NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

COVID-19 2Skin Neoplasms 1Respiratory Sounds 1Neoplasms 1Lymphoma, Follicular 1Hematologic Neoplasms 1Crohn Disease 1Asthma 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Azithromycin × Clear all
NCT05599347 2025-04-04

AZITRATIM

Rambam Health Care Campus

Phase 2 Recruiting
180 enrolled

Crohn Disease

NCT06207786 2024-11-25

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

Mayo Clinic

Phase NA Withdrawn
Dermatologic

Skin Neoplasms

NCT02517099 2023-03-06

PrIGMa

Imperial College London

Phase 2 Completed
60 enrolled 10 charts
Lymphoid

Asthma, Lymphoma, Follicular, Respiratory Sounds

NCT04392128 2020-09-04

HYACINTHE

Institut de cancérologie Strasbourg Europe

Phase 2 Withdrawn
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT04341207 2020-04-10

ONCOVID

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
1,000 enrolled

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡